Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Aclaris Therapeutics (ACRS) Change in Inventory: 2018-2019

Historic Change in Inventory for Aclaris Therapeutics (ACRS) over the last 1 years, with Dec 2019 value amounting to -$3,000.

  • Aclaris Therapeutics' Change in Inventory rose 99.74% to -$3,000 in Q4 2019 from the same period last year, while for Dec 2019 it was -$605,000, marking a year-over-year change of. This contributed to the annual value of -$605,000 for FY2019, which is 493.14% down from last year.
  • According to the latest figures from Q4 2019, Aclaris Therapeutics' Change in Inventory is -$3,000, which was down 175.00% from $4,000 recorded in Q3 2019.
  • Aclaris Therapeutics' Change in Inventory's 5-year high stood at $65,000 during Q1 2019, with a 5-year trough of -$1.1 million in Q4 2018.
  • Its 2-year average for Change in Inventory is -$288,833, with a median of $500 in 2019.
  • Over the last 5 years, Aclaris Therapeutics' Change in Inventory had its largest YoY gain of 99.74% in 2019, and its largest YoY loss of 77.78% in 2019.
  • Over the past 2 years, Aclaris Therapeutics' Change in Inventory (Quarterly) stood at -$1.1 million in 2018, then skyrocketed by 99.74% to -$3,000 in 2019.
  • Its Change in Inventory was -$3,000 in Q4 2019, compared to $4,000 in Q3 2019 and -$671,000 in Q2 2019.